U.S. flag

An official website of the United States government

NC_000012.12:g.120502295_120511884dup AND Coenzyme q10 deficiency, primary, 9

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 25, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001257583.1

Allele description [Variation Report for NC_000012.12:g.120502295_120511884dup]

NC_000012.12:g.120502295_120511884dup

Gene:
COQ5:coenzyme Q5, methyltransferase [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
12q24.31
Genomic location:
Preferred name:
NC_000012.12:g.120502295_120511884dup
HGVS:
  • NC_000012.12:g.120502295_120511884dup
  • NC_000012.11:g.120940098_120949687dup
Nucleotide change:
9.6-KB DUP
Links:
OMIM: 616359.0001

Condition(s)

Name:
Coenzyme q10 deficiency, primary, 9
Identifiers:
MONDO: MONDO:0033615; MedGen: C5436638; OMIM: 619028

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001434392OMIM
no assertion criteria provided
Pathogenic
(Jan 25, 2021)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C-methyltransferase deficiency.

Malicdan MCV, Vilboux T, Ben-Zeev B, Guo J, Eliyahu A, Pode-Shakked B, Dori A, Kakani S, Chandrasekharappa SC, Ferreira CR, Shelestovich N, Marek-Yagel D, Pri-Chen H, Blatt I, Niederhuber JE, He L, Toro C, Taylor RW, Deeken J, Yardeni T, Wallace DC, Gahl WA, et al.

Hum Mutat. 2018 Jan;39(1):69-79. doi: 10.1002/humu.23345. Epub 2017 Nov 8.

PubMed [citation]
PMID:
29044765
PMCID:
PMC5722658

Details of each submission

From OMIM, SCV001434392.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 3 sisters, born of unrelated parents of Iraqi-Jewish descent, with coenzyme Q10 deficiency-9 (COQ10D9; 619028), Malicdan et al. (2018) identified a homozygous 9,590-bp duplication (chr12:120,940,098-120,949,687, GRCh37) in the COQ5 gene. The duplication, which was found by detailed genetic analysis and confirmed by Sanger sequencing, segregated with the disorder in the family. The duplication spanned the last 4 exons of the COQ5 gene, but did not alter the open reading frame: it was located about 1 kb beyond the DNA sequence that encodes the 3-prime untranslated region. Patient fibroblasts and leukocytes, and skeletal muscle tissue from 1 patient, had significantly decreased COQ5 mRNA and protein levels compared to controls. Cultured fibroblasts from 1 patient showed a defect in mitochondrial complex II+III activity and abnormal oxygen consumption, suggesting that the mutation had an adverse effect on mitochondrial respiration. Homozygosity for the variant was not found in 92 healthy individuals from the same ethnic background; however, there were 3 heterozygous carriers, yielding a minor allele frequency of about 1.5%.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 7, 2023